Murawaki Y - Search Results

1

Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT.

Tokunaga S, Koda M, Matono T, Sugihara T, Nagahara T, Ueki M, Murawaki Y, Kakite S, Yamashita E. Tokunaga S, et al. Among authors: murawaki y. Br J Radiol. 2012 Jun;85(1014):745-52. doi: 10.1259/bjr/64518148. Epub 2011 Mar 8. Br J Radiol. 2012. PMID: 21385915 Free PMC article.

2

Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT.

Mandai M, Koda M, Matono T, Nagahara T, Sugihara T, Ueki M, Ohyama K, Murawaki Y. Mandai M, et al. Among authors: murawaki y. Br J Radiol. 2011 Jun;84(1002):499-507. doi: 10.1259/bjr/38682601. Epub 2010 Oct 19. Br J Radiol. 2011. PMID: 20959373 Free PMC article.

3

Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis.

Murawaki Y, Ikuta Y, Nishimura Y, Koda M, Kawasaki H. Murawaki Y, et al. J Gastroenterol Hepatol. 1996 May;11(5):443-50. doi: 10.1111/j.1440-1746.1996.tb00289.x. J Gastroenterol Hepatol. 1996. PMID: 8743916

4

Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease.

Murawaki Y, Ikuta Y, Okamoto K, Koda M, Kawasaki H. Murawaki Y, et al. J Hepatol. 1999 Sep;31(3):474-81. doi: 10.1016/s0168-8278(99)80040-3. J Hepatol. 1999. PMID: 10488707

5

Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma.

Koda M, Murawaki Y, Mitsuda A, Ohyama K, Horie Y, Suou T, Kawasaki H, Ikawa S. Koda M, et al. Among authors: murawaki y. Cancer. 2000 Feb 1;88(3):529-37. Cancer. 2000. PMID: 10649243

6

Liver perforation: a serious complication of percutaneous acetic acid injection for hepatocellular carcinoma.

Koda M, Tanaka H, Murawaki Y, Horie Y, Suou T, Kawasaki H, Ikawa S. Koda M, et al. Among authors: murawaki y. Hepatogastroenterology. 2000 Jul-Aug;47(34):1110-2. Hepatogastroenterology. 2000. PMID: 11020890

7

Changes in esophageal variceal pressure after transcatheter arterial embolization for hepatocellular carcinoma.

Okada K, Koda M, Murawaki Y, Kawasaki H. Okada K, et al. Among authors: murawaki y. Endoscopy. 2001 Jul;33(7):595-600. doi: 10.1055/s-2001-15310. Endoscopy. 2001. PMID: 11473331

8

Plasma matrix metalloproteinase-9 (gelatinase B) in patients with hepatocellular carcinoma.

Murawaki Y, Ikuta Y, Okamoto K, Mimura K, Koda M, Kawasaki H. Murawaki Y, et al. Res Commun Mol Pathol Pharmacol. 2000 Nov-Dec;108(5-6):351-7. Res Commun Mol Pathol Pharmacol. 2000. PMID: 11958288 Clinical Trial.

9

Is choledocholithiasis a late complication of nonresectional therapies for hepatocellular carcinoma?

Koda M, Murawaki Y, Idobe Y, Horie Y, Suou T, Kawasaki H, Ikawa S. Koda M, et al. Among authors: murawaki y. Hepatogastroenterology. 1999 Nov-Dec;46(30):3091-4. Hepatogastroenterology. 1999. PMID: 10626167

10

Renovascular resistance assessed by color Doppler ultrasonography in patients with chronic liver diseases.

Koda M, Murawaki Y, Kawasaki H. Koda M, et al. Among authors: murawaki y. J Gastroenterol Hepatol. 2000 Dec;15(12):1424-9. doi: 10.1046/j.1440-1746.2000.02366.x. J Gastroenterol Hepatol. 2000. PMID: 11197054

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters